Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01614015 · ClinicalTrials.gov registry record · Phase 2
Building Outcomes With Observation-Based Supervision: An FFT Effectiveness Trial
A Phase 2 study of Substance Abuse and Delinquency, sponsored by Oregon Research Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 328
- Enrollment target
- 1
- Study location
NCT01614015: Completed Phase 2 study of Substance Abuse and Delinquency, sponsored by Oregon Research Institute.
NCT01614015 is a Phase 2 study of Substance Abuse and Delinquency that has completed, run by Oregon Research Institute. The registered enrollment target is 328 participants, below the 5,254-participant average among 58 other Substance Abuse trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01614015, a Phase 2 study of Substance Abuse and Delinquency, has completed, sponsored by Oregon Research Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 328 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed effectiveness study examines differences in treatment outcomes of an observation-based supervision (BOOST) versus supervision as usual (SAU). The study will be implemented within 16 teams delivering FFT services at 11 sites in the California Institute of Mental Health (CIMH) system. The 16 FFT therapist teams will be randomly assigned either to BOOST or SAU. Each team will have 3 therapists who will treat 6 families for a total of 18 families per team. Thus, each condition will include 24 therapists who will treat 144 families. The project will be implemented in four staggered waves to establish a more even rate of data collection and treatment implementation to enhance the feasibility of the study by keeping staffing and project costs more constant across the 5-year project. Each wave will involve 4 FFT teams, 2 receiving BOOST and 2 receiving SAU. Teams will be randomized to supervision conditions. Outcome assessments of parents and adolescents will be conducted at baseline and at 4 months and 16 months after treatment initiation.
Primary Outcome
Using V-Timeline Follow Back
Conditions Studied
Interventions
- BEHAVIORAL Supervision
- BEHAVIORAL Observational Supervision
Study Locations (1)
Oregon
- Oregon Research Institute - Eugene
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 328 participants |
| Start Date | 2010-09 |
| Est. Completion | 2016-06 |
| Phase | Phase 2 |
What the finished NCT01614015 record still lists
NCT01614015 is an interventional study that assigns participants to a tested intervention. The registered 328 participants enrollment target is mid-sized for trials with a published cap, below the 5,254-participant average among 58 other Substance Abuse trials with a reported enrollment target (94% lower).
The record links to 3 conditions, with Substance Abuse appearing as the primary indexed condition, and to 2 interventions - of which Supervision is the first listed.
NCT01614015 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT01614015 about?
NCT01614015 is a clinical study titled "Building Outcomes With Observation-Based Supervision: An FFT Effectiveness Trial". The proposed effectiveness study examines differences in treatment outcomes of an observation-based supervision (BOOST) versus supervision as usual (SAU). The study will be implemented within 16 teams delivering FFT services at 11 sites in the California Institute of Mental Health (CIMH) system. The...
What is the current status of trial NCT01614015?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 328 participants. The study started on 2010-09. Estimated completion is 2016-06.
What conditions does trial NCT01614015 study?
This clinical trial studies the following conditions: Substance Abuse, Delinquency, Self Destructive Behavior.
What interventions are being tested in trial NCT01614015?
The interventions under investigation include: Supervision (BEHAVIORAL), Observational Supervision (BEHAVIORAL).
Who is sponsoring clinical trial NCT01614015?
This trial is sponsored by Oregon Research Institute, which has 62 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01614015 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Abuse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01614015's enrollment target sits among peer trials
328 18th of 58 higher than 41 of 58 other Substance Abuse trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Abuse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Enhancing Prevention Capacity With Developmental Assets and Getting to Outcomes
COMPLETED · Phase 2
-
Evaluation of Treatments for Homeless Youths
COMPLETED · Phase 2
-
Substance Treatment and HIV Testing and Referral System
COMPLETED · Phase 2
-
Study of Medical Treatment for Methamphetamine Addiction
COMPLETED · Phase 2
-
Evaluation of Atomoxetine for Cocaine Dependence: A Pilot Trial
COMPLETED · Phase 2
-
Aripiprazole Treatment for Methamphetamine Dependence Among High-risk Individuals
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05156983 · 328 participants · Phase 3
A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery
- NCT05380401 · 328 participants · NA
Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants
- NCT05548413 · 328 participants · NA
Improving Medication Adherence Using Family-focused and Literacy-sensitive Strategies
- NCT06393725 · 328 participants · NA
Synchronous vs Asynchronous Remotely Delivered Lifestyle Interventions
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia